Gene Detection Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030

The global gene detection market is expected to experience significant growth as the prevalence of autoimmune diseases continues to rise worldwide. Various gene detection methods are being utilized for the identification and categorization of hereditary factors contributing to autoimmune diseases such as rheumatoid arthritis, type 1 diabetes, scleroderma, multiple sclerosis, psoriasis, lupus, and Crohn’s disease. The growing demand for more efficient gene detection methods is driving the market's expansion, with advanced techniques like RT-PCR leading the way.

Opportunities Abound in Oncology

The COVID-19 pandemic has accelerated the growth of the gene detection market, with an increasing need for rapid gene detection tests for COVID-19 diagnosis. Additionally, the field of oncology has become a highly attractive area for gene detection research. Multiple cancer-specific gene detection techniques are in development, aligning with the rising prevalence of cancer worldwide. Preventive diagnosis and personalized medicine are gaining momentum, creating a conducive environment for advancements in gene detection methods. With the International Agency for Research on Cancer estimating new cancer incidences to reach 30 million by 2040, gene detection is set to play a significant role in oncology.

Gene Detection Market Continues to Witness Primacy of North America

The growing interest in ancestral analysis is driving demand for gene detection studies, particularly in North America. The region also experiences notably high prevalence of autoimmune diseases, with around 24 million individuals living with such conditions in the US alone, according to the National Institute of Environmental Health Sciences (NIH). This high prevalence has led to an increasing demand for advanced gene detection techniques in developing economies as well. Gene detection kits are gaining popularity as a viable solution to reduce the overall rate of autoimmune disease prevalence and subsequent healthcare expenditure.
The gene detection market in North America stands strong due to the presence of key market players and a rising number of product approvals from the US FDA. Companies engaged in research and development are introducing innovative gene detection methods to the market, further reinforcing North America's position as a global leader in the gene detection market.

Competition Analysis - Global Gene Detection Market

The upcoming report will provide insights into the competitive landscape of the global gene detection market, profiling prominent players and offering exclusive information on their strategic and financial performance. Some of the profiled companies include F Hoffmann-La Roche, Abbott Laboratories, BioRad Laboratories, Danaher, and Illumina Inc.